Use of G-CSF in matched donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee.
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells.
Autorzy:
Stein AM; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA. Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Levine JE; University of Michigan, Ann Arbor, Michigan, USA.; Icahn School of Medicine at Mount Sinai, New York, New York, USA. Laetsch TW; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, Texas, USA. PulsipherMA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, California, USA. Boyer MW; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, Utah, USA. August KJ; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA. Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Tomassian L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. Shah S; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. Leung M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. Huang PH; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. Awasthi R; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA. Mueller KT; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA. Wood PA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Miller TP; a Division of Oncology ; Getz KD; a Division of Oncology ;; b Center for Pediatric Clinical Effectiveness , The Children's Hospital of Philadelphia , Philadelphia , PA , USA ; Kavcic M; a Division of Oncology ; Li Y; a Division of Oncology ;; c Center for Clinical Epidemiology and Biostatistics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ; Huang YS; b Center for Pediatric Clinical Effectiveness , The Children's Hospital of Philadelphia , Philadelphia , PA , USA ; Sung L; d Department of Haematology/Oncology , The Hospital for Sick Children , Toronto , Canada ; Alonzo TA; e Department of Preventative Medicine , University of Southern California , Arcadia , CA , USA ;; f Children's Oncology Group , Monrovia , CA , USA ; Gerbing R; f Children's Oncology Group , Monrovia , CA , USA ; Daves M; g Department of Pediatrics , Children's Healthcare of Atlanta , Atlanta , GA , USA ; Horton TM; h Department of Pediatrics , Section of Hematology-Oncology, Texas Children's Hospital , Houston , TX , USA ; PulsipherMA; i Hematology Division , University of Utah School of Medicine , Salt Lake City , UT , USA ; Pollard J; j Cancer and Blood Disorders Center , Seattle Children's Hospital , Seattle , WA , USA ; Bagatell R; a Division of Oncology ;; k Departments of Pediatrics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ; Seif AE; a Division of Oncology ;; k Departments of Pediatrics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ; Fisher BT; b Center for Pediatric Clinical Effectiveness , The Children's Hospital of Philadelphia , Philadelphia , PA , USA ;; c Center for Clinical Epidemiology and Biostatistics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ;; k Departments of Pediatrics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ;; l Infectious Diseases , The Children's Hospital of Philadelphia , Philadelphia , PA , USA ; Gamis AS; m Pediatric Hematology/Oncology , Children's Mercy Hospital , Kansas City , MO , USA. Aplenc R; a Division of Oncology ;; c Center for Clinical Epidemiology and Biostatistics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ;; k Departments of Pediatrics , University of Pennsylvania School of Medicine , Philadelphia , PA , USA ;; l Infectious Diseases , The Children's Hospital of Philadelphia , Philadelphia , PA , USA ;
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2016 Jul; Vol. 57 (7), pp. 1567-74. Date of Electronic Publication: 2016 Jan 04.
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
Autorzy:
PulsipherMA; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute/University of Utah School of Medicine, Primary Children's Hospital, Salt Lake City, UT, USA. Langholz B; Department of Preventive Medicine, USC Keck School of Medicine, Los Angeles, CA, USA. Wall DA; Manitoba Blood and Marrow Transplant Program, Winnepeg, Manitoba, Canada. Schultz KR; Department of Pediatrics University of BC, BC Children's Hospital, Vancouver, British Columbia, Canada. Bunin N; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Carroll W; NYU Department of Pediatrics and Cancer Institute, NYU Langone Medical Center, New York, NY, USA. Raetz E; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute/University of Utah School of Medicine, Primary Children's Hospital, Salt Lake City, UT, USA. Gardner S; NYU Department of Pediatrics and Cancer Institute, NYU Langone Medical Center, New York, NY, USA. Goyal RK; Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Gastier-Foster J; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pathology, The Ohio State University College of Medicine, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. Borowitz M; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Teachey D; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Grupp SA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Sep; Vol. 50 (9), pp. 1173-9. Date of Electronic Publication: 2015 May 11.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.
Autorzy:
Shaw BE; 1] Anthony Nolan Research Institute, UCL Cancer Institute, London, UK [2] Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, UK. Confer DL; National Marrow Donor Program, Minneapolis, MN, USA. Hwang W; 1] Singapore General Hospital, Singapore City, Singapore [2] Duke-NUS Graduate Medical School, Singapore City, Singapore [3] Singapore Cord Blood Bank, Singapore City, Singapore. PulsipherMA; 1] Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA [2] Primary Children's Hospital, Salt Lake City, UT, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Mar; Vol. 50 (3), pp. 334-40. Date of Electronic Publication: 2015 Jan 19.
New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL.
Autorzy:
PulsipherMA; Division of Hematology and Hematological Malignancies, Primary Children's Hospital, University of Utah School of Medicine/Huntsman Cancer Institute, Salt Lake City, UT, USA. Wayne AS; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, The Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Schultz KR; Department of Pediatrics, University of BC, BC Children's Hospital, Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2014 Oct; Vol. 49 (10), pp. 1259-65. Date of Electronic Publication: 2014 Jun 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Talano JM; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. PulsipherMA; Department of Pediatrics, University of Utah, Salt Lake City, UT, USA. Symons HJ; Department of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA. Militano O; Department of Pediatrics, New York Medical College, Valhalla, NY, USA. Shereck EB; Oregon Health and Science University, Portland, OR, USA. Giller RH; Children's Hospital Colorado, Aurora, CO, USA. Hancock L; Pediatric Blood and Marrow Transplant Consortium, Monrovia, CA, USA. Morris E; Department of Pediatrics, New York Medical College, Valhalla, NY, USA. Cairo MS; 1] Department of Pediatrics, New York Medical College, Valhalla, NY, USA [2] Department of Medicine, New York Medical College, Valhalla, NY, USA [3] Department of Pathology, New York Medical College, Valhalla, NY, USA [4] Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA [5] Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2014 Sep; Vol. 49 (9), pp. 1139-45. Date of Electronic Publication: 2014 May 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Preventable Infections in Children with Leukodystrophy.
Autorzy:
Anderson HM; School of Medicine, Salt Lake City, Utah. Wilkes J; Intermountain Healthcare (J.W., E.K.K.), Salt Lake City, Utah. Korgenski EK; Intermountain Healthcare (J.W., E.K.K.), Salt Lake City, Utah. PulsipherMA; Division of Hematology and Hematological Malignancies (M.A.P.), Salt Lake City, Utah. Blaschke AJ; Division of Pediatric Infectious Diseases (A.J.B., A.L.H.), Salt Lake City, Utah. Hersh AL; Division of Pediatric Infectious Diseases (A.J.B., A.L.H.), Salt Lake City, Utah. Srivastava R; Division of Inpatient Medicine (R.S.), Salt Lake City, Utah. Bonkowsky JL; Division of Pediatric Neurology (J.L.B.), Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah ; Department of Neurology (J.L.B.), Salt Lake City, Utah.
Relationship between pediatric blood and marrow transplant center volume and day +100 mortality: Pediatric Blood and Marrow Transplant Consortium experience.
Bone marrow transplantation [Bone Marrow Transplant] 2012 Feb; Vol. 47 (2), pp. 203-11. Date of Electronic Publication: 2011 Mar 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
